Bruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say

12.02.26 16:30 Uhr

Werte in diesem Artikel
Aktien

31,16 EUR 0,15 EUR 0,48%

For the quarter ended December 2025, Bruker (BRKR) reported revenue of $977.2 million, down 0.2% over the same period last year. EPS came in at $0.59, compared to $0.76 in the year-ago quarter.The reported revenue represents a surprise of +1.12% over the Zacks Consensus Estimate of $966.4 million. With the consensus EPS estimate being $0.65, the EPS surprise was -9.23%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Bruker performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Organic revenue growth - Total: -5.1% versus -7.4% estimated by three analysts on average.Organic revenue growth - Bruker Scientific Instruments (BSI): -5.1% versus -8.2% estimated by two analysts on average.Organic revenue growth - Bruker Energy & Supercon Technologies (BEST): -5.1% compared to the -1.6% average estimate based on two analysts.Revenue- Bruker Energy & Supercon Technologies (BEST): $71.5 million versus the four-analyst average estimate of $72.92 million. The reported number represents a year-over-year change of -0.8%.Revenue- Eliminations: $-2 million compared to the $-3.5 million average estimate based on three analysts. The reported number represents a change of -47.4% year over year.View all Key Company Metrics for Bruker here>>>Shares of Bruker have returned -13.7% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.See Our Newest 5 Stocks Set to Double Picks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bruker Corporation (BRKR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Bruker und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Bruker Corp

Analysen zu Bruker Corp

DatumRatingAnalyst
24.06.2019Bruker Strong BuyNeedham & Company, LLC
30.05.2019Bruker Peer PerformWolfe Research
06.05.2019Bruker Strong BuyNeedham & Company, LLC
12.04.2019Bruker BuyDeutsche Bank AG
12.02.2019Bruker BuyBTIG Research
DatumRatingAnalyst
24.06.2019Bruker Strong BuyNeedham & Company, LLC
06.05.2019Bruker Strong BuyNeedham & Company, LLC
12.04.2019Bruker BuyDeutsche Bank AG
12.02.2019Bruker BuyBTIG Research
03.01.2019Bruker Strong BuyNeedham & Company, LLC
DatumRatingAnalyst
30.05.2019Bruker Peer PerformWolfe Research
18.01.2017Bruker HoldDeutsche Bank AG
04.01.2017Bruker Equal WeightBarclays Capital
05.05.2016Bruker NeutralMizuho
07.01.2016Bruker HoldDeutsche Bank AG
DatumRatingAnalyst
09.10.2018Bruker SellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Bruker Corp nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen